On the upside
Home Diagnostics (Nasdaq: HDIX) will be acquired by Japanese medical device maker Nipro for approximately $215 million.
The Food and Drug Administration approved Labopharm's (Nasdaq: DDSS) once-a-day antidepressant Oleptro Extended Release Tablets.
Fourth quarter earnings for Acme Packet (Nasdaq: APKT) more than doubled due to its acquisition of Covergence last year.
On the downside
Exide Technologies (Nasdaq: XIDE) reported lower third quarter earnings as sales fell.
VeriSign (Nasdaq: VRSN) reported lower fourth quarter income that fell short of estimates.
Fourth quarter earnings for Western Union (NYSE: WU) slipped.
In the broad market, declining issues edged out advancers by a margin of more than 10 to 9 on the NYSE while advancers outpaced decliners by a margin of nearly 7 to 5 on Nasdaq. The Russell 2000 which tracks small cap stocks added a point to 615.